Imaging-guided personalized radiation for skull-base chordoma
Part of Bones, joints & muscles, Brain & nervous system, Cancer clinical trials.
This trial studies how detailed imaging can guide personalized (custom) radiation treatment for skull-base chordoma. It may help doctors plan treatment more accurately using measurements taken before and during therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of skull-base chordoma based on biopsy/pathology results
- Your treatment plan uses particle therapy with the goal to cure (not just relieve symptoms)
- Your strength and daily function are good enough (Karnofsky 60 or higher)
- There is visible (measurable) tumor disease on scans done before radiation starts
- You are receiving particle therapy using the clinic’s standard treatment plan
- You are able to sign consent for the research
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of CT scan that might help doctors see tumors more clearly in tricky areas like the brain, head, neck, liver, pancreas, or prostate. It also looks at people with heart disease who need radiation therapy. The goal is to make radiation treatment more accurate and personalized.
This trial tests whether analyzing blood and tumor samples before and after radiation and surgery can help find personalized markers for chordoma. It is for patients with chordoma of the skull base, spine, or sacrum who will receive radiation before surgery.
This trial is testing a better way to plan proton radiation using MRI images, aiming to deliver treatment more accurately for chordoma or chondrosarcoma in the spine/sacrum area. You may benefit if the trial’s planning method helps target the tumor while sparing nearby healthy tissue.
This trial tests a radiation plan using protons given in either 5 or 25 sessions for chordoma or chondrosarcoma at the skull base. The goal is to shrink or control the tumor while protecting nearby critical nerves and brain structures.
This trial studies people with chordoma (a rare bone/soft-tissue tumor) and collects information and samples to learn more about the disease. It may help by improving understanding of chordoma and supporting future research.
This trial compares two standard treatment approaches—surgery versus definitive radiation—for people with a primary sacral chordoma (a bone tumor at the lower spine/pelvis area). It aims to find which approach works best for controlling the tumor while considering treatment side effects.
Hear when a new Skull Base Chordoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.